Disclosures Yehuda Handelsman has received research grants, consulted with, and received speaker honoraria from Aegerion, Amarin, Amgen, AstraZeneca, Bristol-Myers Squibb, Boehringer Ingelheim, Boehringer Ingelheim Lilly, Gan & Lee, Gilead, Intarcia, Janssen, Lexicon, Lilly, Merck, Merck-Pfizer, Mylan, Novo Nordisk, Regeneron, Sanofi, and Target
You dont just want more collagen
The Asian Data: While not tested in Thailand yet, Mounjaro has incredible results from China (SURMOUNT-CN) and Japan (SURMOUNT-J)
Regulatory submissions are anticipated following successful completion of the Phase III trials, with potential approval timelines dependent on the specific regulatory pathways pursued in different jurisdictions